Furthermore, Jin et al. identified ZEB1-AS1 as a candidate lncRNA, ZEB1-AS1, with clinical therapeutic and prognostic significance for NSCLC patients (Jin et al., 2019). Here, ZEB1 is linked to non-small cell lung carcinoma.